Medical

FDA Study Proves Non-Contact Infrared Thermometers (NCITs) are an Unreliable Temperature Screening Tool

FDA study highlights misleading labeling by NCIT manufacturers Since the start of the pandemic, non-contact infrared thermometers (NCITs) have become the primary tool used in public temperature screenings, even though extensive scientific research has proven that they do not produce reliable or accurate temperature readings. Now, an important new study[1] published by the FDA adds […]

FDA Study Proves Non-Contact Infrared Thermometers (NCITs) are an Unreliable Temperature Screening Tool Read More »

Government of India Has Granted Metrology Certificates to Exergen

Exergen Corporation, the global leader in infrared temperature measurement technologies for medical applications, is pleased to announce that the Government of India has granted Metrology Certificates to Exergen Corp. for its full line of Temporal Artery Thermometers (TAT) for both professional and at-home use. “Receiving Metrology Certificates for the TAT-5000, the TAT-5000S, the TAT-2000 and

Government of India Has Granted Metrology Certificates to Exergen Read More »

US FDA Clinical Study Proves Non-Contact Thermometers Fail To Meet Accuracy Specifications

Exergen: FDA Study Reveals Misleading Labeling by NCIT Manufacturers Regarding Accuracy Since the start of the pandemic, non-contact infrared thermometers (NCITs) have been widely used as a screening method for fever detection in healthcare and public settings, as fever is a leading sign of Covid. Now, a new FDA published study1 demonstrates their failure to

US FDA Clinical Study Proves Non-Contact Thermometers Fail To Meet Accuracy Specifications Read More »

Exergen signs Sidem SpA as distributor for full line of Temporal Artery Thermometers in Italy

Exergen Corporation, the global leader in infrared temperature measurement technologies for medical applications, is excited to announce that Exergen and Sidem SpA have signed an agreement for the sales and distribution in Italy of the full line of Temporal Artery Thermometers for both professional and at-home use. “Sidem SpA is based near Milan. We are

Exergen signs Sidem SpA as distributor for full line of Temporal Artery Thermometers in Italy Read More »

TemporalScanner, Now Backed By More Than 100 Clinical Studies, Sets Milestone For Proven Accuracy

TemporalScanner Sets Milestone For Proven Accuracy The Only Thermometer with Deep Body of Peer-Reviewed, Published Studies Supporting Accuracy, Non-Invasiveness Across All Healthcare Settings Since Exergen Corporation introduced its TemporalScanner more than 20 years ago, the thermometer has received unmatched support from the medical community for its accuracy, non-invasiveness, convenience, and reliability. Exergen, a U.S. company

TemporalScanner, Now Backed By More Than 100 Clinical Studies, Sets Milestone For Proven Accuracy Read More »

Survey Shows Skepticism In U.S. On Accuracy Of Non-Contact Temperature Screenings For COVID-19 And Its Variants

  Americans Want Accuracy in Public Temperature Screenings A new national online survey conducted by The Harris Poll on behalf of the Exergen Corporation shows that over two-thirds of Americans (68%) want thermometers to be used in public spaces to screening for COVID-19 and its variants during cold and flu season this upcoming fall and

Survey Shows Skepticism In U.S. On Accuracy Of Non-Contact Temperature Screenings For COVID-19 And Its Variants Read More »

Exergen Fights High Cost Of Healthcare And Impact Of Hospital Medical Waste On Climate Change With “Green Cash Flow” Trade-Up Program

One thing has remained constant with U.S. healthcare: it keeps getting more expensive. The American Medical Association reports1 that medical expenditures increased by 4.6% in 2019 to $3.8 trillion. This followed a 4.7% jump in 2018 and 4.6% increase in 2016. At the same time, medical waste is one of the top contributors to greenhouse gas emissions

Exergen Fights High Cost Of Healthcare And Impact Of Hospital Medical Waste On Climate Change With “Green Cash Flow” Trade-Up Program Read More »

Exergen Duke University Study Shows Corporate Senior Managers Endorse Ineffective Non-Contact Thermometer Screenings Against Medical Director’s Advice

Companies Implement Ineffective Screenings to Give Employees and Customers Misleading Reassurance A new study[1] published in the Journal of Occupational and Environmental Medicine (JOEM) shows senior management overriding the advice of their medical directors regarding screening employees with non-contact thermometers. The study also shows non-contact thermometers are inaccurate, and those screenings are not recommended by

Exergen Duke University Study Shows Corporate Senior Managers Endorse Ineffective Non-Contact Thermometer Screenings Against Medical Director’s Advice Read More »

Exergen: New Study Shows Pro Athletes In Closed Campus “Bubble” Who Tested Positive For COVID-19 But Were Asymptomatic Did Not Transmit The Virus

A new study1 published by JAMA Network proves that individuals, in this case, young, healthy, male basketball players, who tested positive for COVID-19 but were asymptomatic, did not spread the virus despite being in a closed, isolation “bubble” over a period of months. Over approximately four months, nearly 4,000 basketball players, staff, and vendors interacted

Exergen: New Study Shows Pro Athletes In Closed Campus “Bubble” Who Tested Positive For COVID-19 But Were Asymptomatic Did Not Transmit The Virus Read More »

Exergen Corporation Expands Into Switzerland

Signs marketing and distribution agreement with ITRIS Medical AG for the full line of professional non-invasive high-tech thermometers for hospitals and healthcare institutions   Exergen Corporation, a global leader in infrared temperature measurement technologies for medical applications, announced today that it has signed a marketing and distribution contract with ITRIS Medical AG to market the

Exergen Corporation Expands Into Switzerland Read More »